GlassScriptPhysician profile
Ravi Chandran
NPI 1043496235
$5,169.81
in general payments reported to CMS, 2019-2025
15 companies · $606 in 2025
The $606 reported for 2025 was more than what 81% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,750 · 2020: $502 · 2021: $1,133 · 2022: $596 · 2023: $565 · 2024: $17.73 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,771.11 | 2019-2021 | |
| Stryker Corporation | $958.81 | 2019-2025 | Vsp System, Vsp Cranial |
| Kls-Martin L.P. | $491.69 | 2019-2022 | |
| Straumann USA LLC | $457.35 | 2025 | |
| Zimvie INC. | $449.98 | 2022-2023 | |
| Geistlich Pharma, North America, INC. | $251.22 | 2019-2023 | Bio-Gide, Bio-Materials |
| Axogen | $238.65 | 2019-2020 | |
| Depuy Synthes Sales INC. | $234.21 | 2019 | |
| Keystone Dental INC. | $88.66 | 2022 | |
| Integra Lifesciences Corporation | $83.34 | 2019 | |
| Biohorizons Implant Systems INC. | $76.34 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply Sirona INC | $21.51 | 2022 | |
| Olympus America INC. | $18.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.17 | 2023 | Exparel |
| Nobel Biocare USA | $12.77 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Chandran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.